US2010268336A1PendingUtilityA1

Materials and Method for Promotion of Nerve Regeneration

Individually held — no corporate assignee on recordPriority: Jan 30, 2004Filed: Jun 28, 2010Published: Oct 21, 2010
Est. expiryJan 30, 2024(expired)· nominal 20-yr term from priority
A61K 38/47A61K 38/51A61P 25/28A61L 2300/254A61L 2430/32A61P 25/00A61L 27/227A61L 27/54
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The subject invention pertains to the therapeutic use of certain GAG-degrading enzymes, and enzyme combinations, to promote nerve repair and regeneration.

Claims

exact text as granted — not AI-modified
1 . A method for preparing a nerve graft for implantation comprising applying at least one heparin sulfate proteoglycan-degrading enzyme to the nerve graft. 
     
     
         2 . The method, according to  claim 1 , which comprises administering a heparan sulfate proteoglycan-degrading enzyme that is selected from the group consisting of heparinase heparinase III, heparinase; and matrix metalloproteinase. 
     
     
         3 . The method, according to  claim 2 , wherein said enzyme is heparinase I or heparinase III. 
     
     
         4 . The method, according to  claim 1 , further comprising administering at least one other GAG-degrading enzyme to the nerve. 
     
     
         5 . The method, according to  claim 1 , further comprising administering to the nerve at least one chondroitin sulfate proteoglycan-degrading enzyme. 
     
     
         6 . The method, according to  claim 5 , wherein the chondroitin sulfate proteoglycan-degrading enzyme is selected ftom the group consisting of chondroitinase ABC, chondroitinase A, chondroitinase C, and chondroitinase AC. 
     
     
         7 . The method, according to  claim 1 , further comprising administering to the nerve at least one keratan sulfate proteoglycan-degrading enzyme. 
     
     
         8 . The method, according to  claim 7 , wherein said keratin sulfate proteoglycan-degrading enzyme is keratanase or endo-b-galactosidase. 
     
     
         9 . A nerve graft for implantation comprising nerve tissue prepared by a method comprising applying at least one heparin sulfate proteoglycan-degrading enzyme to the nerve tissue.

Join the waitlist — get patent alerts

Track US2010268336A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.